Activity value 90International Buyer&Supplier,Last transaction date:
2026-05-19Address: dinamarca,copenhague,dalslandsgade 11 dk-2300
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for xellia pharmaceuticals aps from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 31 transactions, with a transaction quantity of 1934.86 and a transaction weight of 835.22.
YearTransactionsQuantityWeight
20252333114275.7552861.2
2026311934.86835.22
Bill of lading data
<
1/15
>
Trade date
2026/05/19
B/L No.
——
Suppliers
xellia pharmaceuticals aps
Buyers
m/s zas corporation
Hs code
29419090
Product tags
polymyxin b sulphate,usp ep,st micro
Product description
POLYMYXIN B SULPHATE NST MICRONIZED 10 BOU USP EP IP 5032 GRAM POLYMYXIN B SULPHATE NST MICRONIZED 10 BOU USP EP IP 503
Expand
Trade date
2026/02/19
B/L No.
——
Suppliers
xellia pharmaceuticals aps
Buyers
laboratorio de productos eticos comercial e industrial s.a.
POLs
——
PODs
codesa
Supply area
Denmark
Purchas area
Paraguay
Weight
1.28kg
Amount
7902
Hs code
29419081
Product tags
antibiotics
Product description
PRODUCTOS QUIMICOS ORGANICOS ANTIBIOTICOS. -LOS DEMAS. POLIPEPTIDOS Y SUS SALES. POLIMIXINAS Y SUS SALES.. LOS DEMAS. ANTIBIOTICOS. PRODUCTOS QUIMICOS ORGANICOS. / POLIMIXINA B SULFATO
Expand
5civica corp.
united statesbuyer,they trade on 2024-11-23
672.28%
>
+View All
Products
Total 142
ProductsTransactionsPerDetail
vancomycin 20933.87%>
cod 12319.94%>
e 30 12119.61%>
bat 538.59%>
a1 508.1%>
+View All
Hscode rank
Total 82
HSCode NameTransactionsPerDetail
HS 30042016426.58%>
HS 2941909010216.53%>
HS 40169980426.81%>
HS 29419089000294.7%>
HS 29339990264.21%>
+View All
Trading Area
Total 21
AreaTransactionsPerDetail
united states58820.03%>
india45715.57%>
argentina1555.28%>
colombia1384.70%>
brazil872.96%>
+View All
Port statistics
Total 33
Port NameTransactionsPerDetail
genoa1685.72%>
bremerhaven1595.42%>
hamburg1113.78%>
antwerp812.76%>
rotterdam371.26%>
+View All
xellia pharmaceuticals aps is International Buyer&Supplier,
and primarily engages in the import and export business of products such as vancomycin,cod,e 30.
According to the 52wmb.com global trade database, as of 2026-05-19, the company has completed 2935 international trades,
with its main trading regions covering united states,india,argentina etc.
The core products include HS300420,HS29419090,HS40169980 etc,
often transported via genoa,port bremerhaven, port hamburg etc,
and its main trading partners are xellia pharmaceuticals aps,gland pharma,xellia pharmaceuticals pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on xellia pharmaceuticals aps is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.